InsiderTrades

Form 4 for LXEO Lexeo Therapeutics, Inc.

Accepted 2025-10-17 00:00:00 ET · period of report 2025-10-15 · accession 0001995009-25-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-10-17 2025-10-17 LXEO Robertson Jenny CLO S - Sale $8.95 -3,526 69.0K -5% -$31.5K
2025-10-17 2025-10-15 LXEO Robertson Jenny CLO A - Grant $0.00 +9,900 72.5K +16% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-10-17 S D 40 $9.56 68,930 D — — (F3) This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F4) Includes 51,092 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
2 Common Common Stock 2025-10-17 S D 3,486 $8.94 68,970 D — — (F2) This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Common Common Stock 2025-10-15 A A 9,900 $0.00 72,456 D — —